DENVAX Treatment of Recurrent Bone Cancer : Success Story of Shribhan Yadav | Dr Jamal | Dr Sharmin

This is a success story of patient Mr. Shribhan Yadav who was diagnosed with Osteosarcoma, which is cancer of the bone, in 2017. Mr. Shribhan who was having multiple recurrences and surgeries opted for Denvax Cancer Immunotherapy in October 2019. He has been receiving Denvax and has shown complete resolution of disease with PET CT negative status, twice. Currently, his treatment is on-going and continues to receive Denvax therapy.
Denvax Cancer Immunotherapy is a Cell-based cancer treatment for solid tumors in any stage. The treatment is safe, and effective against most cancers. It works to prevent relapse in cancer. It also works as palliative therapy and prolonging life. Denvax is adjuvant/ additional treatment plan. It can be safely given as combination therapy, along with Chemotherapy, radiation (Radiotherapy) and Surgery.
Dr. Jamal A. Khan and Dr. Sharmin Yaqin have co-founded Denvax Cancer Immunotherapy. Together, they are in clinical practice in exclusive Dendritic cell therapy (Denvax) for the past 17 years. They pioneered the work in customized Immunotherapy in India in the year 2004. They have a large number of patients who are cancer survivors. Through the videos they intend to share patient experiences for better understanding of Denvax treatment and its process.
The Denvax clinics are owned and managed by Dr. Jamal and Dr. Sharmin. They are a team of doctors and paramedical staff who are engaged in administering of this customized treatment protocol. They can be reached at [e-mail]. Patients may Whatsapp their reports at [phone].
Log on to the website to understand more: www.denvaxindia.com
#osteosarcoma #Dr Jamal A Khan #Denvax #Dr Sharmin #Denvax Cancer Immunotherapy #Cancer immunotherapy
Music: www.purple-planet.com